FrancophonIA/ELRC3.0 huggingface dataset:
English: Aranesp 10 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 10 micrograms of darbepoetin alfa in 0.4 mL (25 mcg/mL).
Estonian: Aranesp 10 mikrogrammi süstelahus süstlis Iga süstel sisaldab 10 mikrogrammi alfadarbepoetiini 0,4 ml-s (25 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 300 micrograms solution for injection in pre-filled pen Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 300 mikrogrammi süstelahus pen-süstlis Alfadarbepoetiin
English: NAME OF THE MEDICINAL PRODUCT Aranesp 40 micrograms solution for injection in pre-filled pen Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 40 mikrogrammi süstelahus pen-süstlis Alfadarbepoetiin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/052 1 pack
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/052 1-ne pakend
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/038
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/038
English: EU/1/01/185/013 1 pack EU/1/01/185/014 4 pack EU/1/01/185/086 1 pack with needle guard EU/1/01/185/087 4 pack with needle guard
Estonian: EU/1/01/185/013 1 süstel pakendis EU/1/01/185/014 4 süstlit pakendis EU/1/01/185/086 1 nõelakaitsega süstel pakendis EU/1/01/185/087 4 nõelakaitsega süstlit pakendis
English: NAME OF THE MEDICINAL PRODUCT Aranesp 100 µg injection
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 100 mikrogrammi süstelahus viaalis Alfadarbepoetiin
English: Aranesp 30 micrograms solution for injection in pre-filled syringe.
Estonian: Aranesp 30 mikrogrammi süstelahus süstlis.
English: Aranesp 50 micrograms solution for injection in pre-filled syringe.
Estonian: Aranesp 50 mikrogrammi süstelahus süstlis.
English: Aranesp 500 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 500 micrograms of darbepoetin alfa in 1 mL (500 mcg/mL).
Estonian: Aranesp 500 mikrogrammi süstelahus süstlis Iga süstel sisaldab 500 mikrogrammi alfadarbepoetiini 1 ml-s (500 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 15 micrograms solution for injection in pre-filled pen Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 15 mikrogrammi süstelahus pen-süstlis Alfadarbepoetiin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/035
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/035
English: Aranesp 300 micrograms solution for injection in vial 1 mL solution for injection (300 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Estonian: 1 ml süstelahust (alfadarbepoetiin 300 µg/ml) I tüüpi klaasist viaalis fluoropolümeerlaminaadiga elastomeerist sulguriga ning alumiiniumkatte ja ärarebitava tolmukattega.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.3 mL pre-filled pen contains 150 micrograms darbepoetin alfa (500 micrograms/mL).
Estonian: TOIMEAINE(TE) SISALDUS Iga 0,3 ml pen-süstel sisaldab 150 mikrogrammi alfadarbepoetiini (500 mikrogrammi/ml).
English: Aranesp 300 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 300 micrograms of darbepoetin alfa in 0.6 mL (500 mcg/mL).
Estonian: Aranesp 300 mikrogrammi süstelahus süstlis Iga süstel sisaldab 300 mikrogrammi alfadarbepoetiini 0,6 ml-s (500 µg/ml).
English: Aranesp 40 micrograms solution for injection in vial 1 mL solution for injection (40 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Estonian: 1 ml süstelahust (alfadarbepoetiin 40 µg/ml) I tüüpi klaasist viaalis fluoropolümeerlaminaadiga elastomeerist sulguriga ning alumiiniumkatte ja ärarebitava tolmukattega.
English: Talk to your doctor, pharmacist or nurse before using Aranesp.
Estonian: Enne Aranesp'i kasutamist pidage nõu oma arsti, apteekri või meditsiiniõega.
English: You should contact your doctor, nurse or pharmacist if this does happen.
Estonian: Sellisel juhul pidage nõu arsti, meditsiiniõe või apteekriga.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 500 micrograms solution for injection in pre-filled pen Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 500 mikrogrammi süstelahus pen-süstlis Alfadarbepoetiin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/102 1 pack
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/102 1 viaaliga pakend
English: Aranesp 300 micrograms solution for injection in vial Each vial contains 3.79 mg of sodium.
Estonian: Aranesp 300 mikrogrammi süstelahus viaalis Iga viaal sisaldab 3,79 mg naatriumi.
English: Aranesp 50 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 1.90 mg of sodium in 0.5 mL.
Estonian: Aranesp 50 mikrogrammi süstelahus pen-süstlis Iga pen-süstel sisaldab 1,90 mg naatriumi 0,5 ml-s.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.5 mL pre-filled pen contains 50 micrograms darbepoetin alfa (100 micrograms/mL).
Estonian: TOIMEAINE(TE) SISALDUS Iga 0,5 ml pen-süstel sisaldab 50 mikrogrammi alfadarbepoetiini (100 mikrogrammi/ml).
English: Aranesp 100 micrograms solution for injection in pre-filled pen.
Estonian: Aranesp 100 mikrogrammi süstelahus pen-süstlis.
English: Aranesp 80 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.52 mg of sodium in 0.4 mL.
Estonian: Aranesp 80 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,52 mg naatriumi 0,4 ml-s.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 20 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 20 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/053 1 pack
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/053 1-ne pakend
English: EU/1/01/185/061 4 pack
Estonian: EU/1/01/185/061 4-ne pakend
English: Aranesp 40 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 1.52 mg of sodium in 0.4 mL.
Estonian: Aranesp 40 mikrogrammi süstelahus pen-süstlis Iga pen-süstel sisaldab 1,52 mg naatriumi 0,4 ml-s.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.5 mL pre-filled syringe contains 50 micrograms darbepoetin alfa (100 micrograms/mL).
Estonian: TOIMEAINE(TE) SISALDUS Iga 0,5 ml süstel sisaldab 50 mikrogrammi alfadarbepoetiini (100 mikrogrammi/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 10 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 10 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/055 1 pack
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/055 1-ne pakend
English: NAME OF THE MEDICINAL PRODUCT Aranesp 100 micrograms solution for injection in pre-filled pen Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 100 mikrogrammi süstelahus pen-süstlis Alfadarbepoetiin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/100 1 pack
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/100 1 viaaliga pakend
English: NAME OF THE MEDICINAL PRODUCT Aranesp 60 µg injection
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 60 mikrogrammi süstelahus viaalis Alfadarbepoetiin
English: EU/1/01/185/058 4 pack
Estonian: EU/1/01/185/058 4-ne pakend
English: EU/1/01/185/060 4 pack
Estonian: EU/1/01/185/060 4-ne pakend
English: EU/1/01/185/068 - 4 pack
Estonian: EU/1/01/185/068 4-ne pakend
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.5 mL pre-filled syringe contains 100 micrograms darbepoetin alfa (200 micrograms/mL).
Estonian: TOIMEAINE(TE) SISALDUS Iga 0,5 ml süstel sisaldab 100 mikrogrammi alfadarbepoetiini (200 mikrogrammi/ml).
English: Aranesp 100 micrograms solution for injection in vial 1 mL solution for injection (100 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Estonian: 1 ml süstelahust (alfadarbepoetiin 100 µg/ml) I tüüpi klaasist viaalis fluoropolümeerlaminaadiga elastomeerist sulguriga ning alumiiniumkatte ja ärarebitava tolmukattega.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 30 µg injection
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 30 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: Aranesp 50 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 50 micrograms of darbepoetin alfa in 0.5 mL (100 mcg/mL).
Estonian: Aranesp 50 mikrogrammi süstelahus süstlis Iga süstel sisaldab 50 mikrogrammi alfadarbepoetiini 0,5 ml-s (100 µg/ml).
English: EU/1/01/185/063 4 pack
Estonian: EU/1/01/185/063 4-ne pakend
English: Aranesp 100 micrograms solution for injection in vial Each vial contains 3.79 mg of sodium.
Estonian: Aranesp 100 mikrogrammi süstelahus viaalis Iga viaal sisaldab 3,79 mg naatriumi.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.5 mL pre-filled pen contains 100 micrograms darbepoetin alfa (200 micrograms/mL).
Estonian: TOIMEAINE(TE) SISALDUS Iga 0,5 ml pen-süstel sisaldab 100 mikrogrammi alfadarbepoetiini (200 mikrogrammi/ml).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/041
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/041
English: NAME OF THE MEDICINAL PRODUCT Aranesp 50 micrograms solution for injection in pre-filled pen Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 50 mikrogrammi süstelahus pen-süstlis Alfadarbepoetiin
English: Aranesp 60 micrograms solution for injection in vial 1 mL solution for injection (60 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Estonian: 1 ml süstelahust (alfadarbepoetiin 60 µg/ml) I tüüpi klaasist viaalis fluoropolümeerlaminaadiga elastomeerist sulguriga ning alumiiniumkatte ja ärarebitava tolmukattega.
English: Aranesp 100 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.90 mg of sodium in 0.5 mL.
Estonian: Aranesp 100 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,90 mg naatriumi 0,5 ml-s.
English: Aranesp 100 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 1.90 mg of sodium in 0.5 mL.
Estonian: Aranesp 100 mikrogrammi süstelahus pen-süstlis Iga pen-süstel sisaldab 1,90 mg naatriumi 0,5 ml-s.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 40 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 40 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: NAME OF THE MEDICINAL PRODUCT Aranesp 500 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 500 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: NAME OF THE MEDICINAL PRODUCT Aranesp 60 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 60 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: Aranesp 40 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.52 mg of sodium in 0.4 mL.
Estonian: Aranesp 40 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,52 mg naatriumi 0,4 ml-s.
English: d Oedema: includes PT Oedema Peripheral, Oedema, Generalised Oedema, Oedema due to Cardiac Disease, Face oedema e Injection site pain adverse reaction includes PT injection site pain, administration site pain, catheter site pain, infusion site pain and vessel puncture site pain.
Estonian: e Süstekoha valulikkus on manustamisjärgne valu süstekohas, manustamiskoha valulikkus, kateetri sisestuskoha valulikkus, infusioonikoha valulikkus ja soone läbistamiskoha valulikkus.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 15 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 15 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: Aranesp 30 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.14 mg of sodium in 0.3 mL.
Estonian: Aranesp 30 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,14 mg naatriumi 0,3 ml-s.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.6 mL pre-filled pen contains 300 micrograms darbepoetin alfa (500 micrograms/mL).
Estonian: TOIMEAINE(TE) SISALDUS Iga 0,6 ml pen-süstel sisaldab 300 mikrogrammi alfadarbepoetiini (500 mikrogrammi/ml).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/050 1 pack
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/050 1-ne pakend
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.3 mL pre-filled pen contains 60 micrograms darbepoetin alfa (200 micrograms/mL).
Estonian: TOIMEAINE(TE) SISALDUS Iga 0,3 ml pen-süstel sisaldab 60 mikrogrammi alfadarbepoetiini (200 mikrogrammi/ml).
English: EU/1/01/185/064 4 pack
Estonian: EU/1/01/185/064 4-ne pakend
English: NAME OF THE MEDICINAL PRODUCT Aranesp 300 µg injection
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 300 mikrogrammi süstelahus viaalis Alfadarbepoetiin
English: Grey needle cap off
Estonian: Hall nõelakate on eemaldatud
English: Your injection is to be given under the skin (subcutaneous), and so you may use the Aranesp pre-filled pen.
Estonian: Kuna süstitakse naha alla (subkutaanne süste), saate kasutada Aranesp'i pen-süstlit.
English: Aranesp 100 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 100 micrograms of darbepoetin alfa in 0.5 mL (200 mcg/mL).
Estonian: Aranesp 100 mikrogrammi süstelahus süstlis Iga süstel sisaldab 100 mikrogrammi alfadarbepoetiini 0,5 ml-s (200 µg/ml).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/051 1 pack
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/01/185/051 1-ne pakend
English: Aranesp 15 micrograms solution for injection in pre-filled syringe 0.375 mL solution for injection (40 mcg/mL darbepoetin alfa) in a type 1 glass pre-filled syringe with stainless steel 27 gauge needle.
Estonian: 0,375 ml süstelahust (alfadarbepoetiin 40 µg/ml) I tüüpi klaasist süstlis koos roostevabast terasest nõelaga mõõdus 27.
English: Aranesp 50 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.90 mg of sodium in 0.5 mL.
Estonian: Aranesp 50 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,90 mg naatriumi 0,5 ml-s.
English: EU/1/01/185/065 4 pack
Estonian: EU/1/01/185/065 4-ne pakend
English: NAME OF THE MEDICINAL PRODUCT Aranesp 40 µg injection
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 40 mikrogrammi süstelahus viaalis Alfadarbepoetiin
English: Aranesp 40 micrograms solution for injection in pre-filled syringe 0.4 mL solution for injection (100 mcg/mL darbepoetin alfa) in a type 1 glass pre-filled syringe with stainless steel 27 gauge needle.
Estonian: 0,4 ml süstelahust (alfadarbepoetiin 100 µg/ml) I tüüpi klaasist süstlis koos roostevabast terasest nõelaga mõõdus 27.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 50 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 50 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: EU/1/01/185/017 1 pack EU/1/01/185/018 4 pack EU/1/01/185/090 1 pack with needle guard EU/1/01/185/091 4 pack with needle guard
Estonian: EU/1/01/185/017 1 süstel pakendis EU/1/01/185/018 4 süstlit pakendis EU/1/01/185/090 1 nõelakaitsega süstel pakendis EU/1/01/185/091 4 nõelakaitsega süstlit pakendis
English: NAME OF THE MEDICINAL PRODUCT Aranesp 300 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 300 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: Aranesp 15 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.42 mg of sodium in 0.375 mL.
Estonian: Aranesp 15 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,42 mg naatriumi 0,375 ml-s. Aranesp 20 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,90 mg naatriumi 0,5 ml-s.
English: Aranesp 10 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.52 mg of sodium in 0.4 mL.
Estonian: Aranesp 10 mikrogrammi süstelahus süstlis Iga süstel sisaldab 1,52 mg naatriumi 0,4 ml-s.
English: What is in this leaflet
Estonian: mille keskel on vill.
English: Aranesp 15 micrograms solution for injection in pre-filled pen 0.375 mL solution for injection (40 mcg/mL darbepoetin alfa) in a pre-filled pen with type 1 glass syringe and stainless steel 27 gauge needle.
Estonian: 0,375 ml süstelahust (alfadarbepoetiin 40 µg/ml) pen-süstlis, I tüüpi klaasist süstliga ja roostevabast terasest nõelaga mõõdus 27.
English: Aranesp 30 micrograms solution for injection in pre-filled syringe 0.3 mL solution for injection (100 mcg/mL darbepoetin alfa) in a type 1 glass pre-filled syringe with stainless steel 27 gauge needle.
Estonian: 0,3 ml süstelahust (alfadarbepoetiin 100 µg/ml) I tüüpi klaasist süstlis koos roostevabast terasest nõelaga mõõdus 27.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PRE-FILLED SYRINGE CARTON WITH TRAY
Estonian: VÄLISPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED ALUSEGA SÜSTLITE KARP
English: NAME OF THE MEDICINAL PRODUCT Aranesp 100 micrograms solution for injection in pre-filled syringe Darbepoetin alfa
Estonian: RAVIMPREPARAADI NIMETUS Aranesp 100 mikrogrammi süstelahus süstlis Alfadarbepoetiin
English: Keep the pre-filled pen in the outer carton in order to protect from light.
Estonian: Hoida pen-süstel originaalpakendis valguse eest kaitstult.
English: Aranesp 15 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 1.42 mg of sodium in 0.375 mL.
Estonian: Aranesp 15 mikrogrammi süstelahus pen-süstlis Iga pen-süstel sisaldab 1,42 mg naatriumi 0,375 ml-s. Aranesp 20 mikrogrammi süstelahus pen-süstlis Iga pen-süstel sisaldab 1,90 mg naatriumi 0,5 ml-s.
English: LIST OF EXCIPIENTS
Estonian: Kõlblikkusaeg (EXP)
English: Convulsions were common in the placebo groups.
Estonian: Platseeborühmas oli krampe sageli.
English: a Hypersensitivity events includes all events under the hypersensitivity SMQ.
Estonian: a Ülitundlikkusreaktsioonideks loetakse kõik standarditud MedDRA päringus toodud ülitundlikkuse juhud.
English: Uncommon1
Estonian: Aeg-ajalt1
English: K Examine the injection site.
Estonian: K Kontrollige süstekohta.
English: Darbepoetin alfa
Estonian: SÜSTLI ALUS
English: Aranesp 40 micrograms solution for injection in pre-filled pen 0.4 mL solution for injection (100 mcg/mL darbepoetin alfa) in a pre-filled pen with type 1 glass syringe and stainless steel 27 gauge needle.
Estonian: 0,4 ml süstelahust (alfadarbepoetiin 100 µg/ml) pen-süstlis, I tüüpi klaasist süstliga ja roostevabast terasest nõelaga mõõdus 27.
English: Upper arm Stomach area (abdomen)
Estonian: Õlavars Kõhupiirkond
English: Aranesp 60 micrograms solution for injection in pre-filled syringe 0.3 mL solution for injection (200 mcg/mL darbepoetin alfa) in a type 1 glass pre-filled syringe with stainless steel 27 gauge needle.
Estonian: 0,3 ml süstelahust (alfadarbepoetiin 200 µg/ml) I tüüpi klaasist süstlis koos roostevabast terasest nõelaga mõõdus 27.
English: The frequency is estimated from clinical trial data as uncommon in CRF patients.
Estonian: Kliiniliste uuringute andmetel esineb KNP-ga patsientidel neid aeg-ajalt.
English: Grab the pre-filled syringe safety guard to remove the pre-filled syringe from the tray.
Estonian: Süstli pakendist välja võtmiseks võtke kinni süstli turvakaitsest.
English: Aranesp 50 micrograms solution for injection in pre-filled syringe 0.5 mL solution for injection (100 mcg/mL darbepoetin alfa) in a type 1 glass pre-filled syringe with stainless steel 27 gauge needle.
Estonian: 0,5 ml süstelahust (alfadarbepoetiin 100 µg/ml) I tüüpi klaasist süstlis koos roostevabast terasest nõelaga mõõdus 27.
English: Do not reuse the pre-filled pen.
Estonian: Ärge kasutage pen-süstlit korduvalt.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 500 µg injection
Estonian: Aranesp 500 mikrogrammi süstelahus süstlis
English: Aranesp 130 micrograms solution for injection in pre-filled pen 0.65 mL solution for injection (200 mcg/mL darbepoetin alfa) in a pre-filled pen with type 1 glass syringe and stainless steel 27 gauge needle.
Estonian: 0,65 ml süstelahust (alfadarbepoetiin 200 µg/ml) pen-süstlis, I tüüpi klaasist süstliga ja roostevabast terasest nõelaga mõõdus 27.
English: Posology
Estonian: Alfadarbepoetiin
English: Aranesp 100 micrograms solution for injection in pre-filled pen 0.5 mL solution for injection (200 mcg/mL darbepoetin alfa) in a pre-filled pen with type 1 glass syringe and stainless steel 27 gauge needle.
Estonian: 0,5 ml süstelahust (alfadarbepoetiin 200 µg/ml) pen-süstlis, I tüüpi klaasist süstliga ja roostevabast terasest nõelaga mõõdus 27.
English: Aranesp 30 micrograms solution for injection in pre-filled pen 0.3 mL solution for injection (100 mcg/mL darbepoetin alfa) in a pre-filled pen with type 1 glass syringe and stainless steel 27 gauge needle.
Estonian: 0,3 ml süstelahust (alfadarbepoetiin 100 µg/ml) pen-süstlis, I tüüpi klaasist süstliga ja roostevabast terasest nõelaga mõõdus 27.
English: Aranesp 500 micrograms solution for injection in pre-filled syringe 1 mL solution for injection (500 mcg/mL darbepoetin alfa) in a type 1 glass pre-filled syringe with stainless steel 27 gauge needle.
Estonian: 1 ml süstelahust (alfadarbepoetiin 500 µg/ml) I tüüpi klaasist süstlis koos roostevabast terasest nõelaga mõõdus 27.
English: Aranesp 60 micrograms solution for injection in pre-filled pen 0.3 mL solution for injection (200 mcg/mL darbepoetin alfa) in a pre-filled pen with type 1 glass syringe and stainless steel 27 gauge needle.
Estonian: 0,3 ml süstelahust (alfadarbepoetiin 200 µg/ml) pen-süstlis, I tüüpi klaasist süstliga ja roostevabast terasest nõelaga mõõdus 27.
English: Subcutaneous use pre-filled syringe (glass)
Estonian: 6 mg Süstelahus Subkutaanne süstel (klaas)
English: (Invented) name
Estonian: Nr Euroopa Liidus (Väljamõeldud) nimetus
English: The design of some of these studies, which were carried out a few years ago, was not aligned with the latest recommendations for the study of new antibiotics.
Estonian: Neist mõne mõned aastad tagasi läbi viidud uuringu ülesehitus ei vastanud uute antibiootikumide uurimise uusimatele soovitustele.
English: This may help to treat some types of bacterial infections.
Estonian: See võib aidata ravida teatud liiki bakteriaalseid nakkusi.
English: If you are in a clinical trial and need more information about your treatment, contact the doctor who is giving it to you.
Estonian: Kui te osalete kliinilises uuringus ja soovite oma ravi kohta lisateavet, võtke palun ühendust teile selle ravi määranud arstiga.
English: Following the CHMP's opinion, it usually takes around 2 months for the European Commission to grant a licence.
Estonian: Inimtervishoius kasutatavate ravimite komitee arvamuse avaldamise järel kulub tavaliselt ligikaudu 2 kuud, enne kui Euroopa Komisjon müügiloa väljastab.
English: The application was at day 180 when the company withdrew.
Estonian: Taotluse menetlemine oli kestnud 180 päeva, kui ettevõte taotluse tagasi võttis.
English: In all studies, the main measure of effectiveness was the proportion of patients whose infection had been cured, at least five days after the end of treatment, although time at which the effectiveness was assessed depended on the type of infection being treated.
Estonian: Kõikides uuringutes mõõdeti efektiivsust põhiliselt nende patsientide osakaalu järgi, kelle nakkus oli kadunud vähemalt viie päeva möödumisel ravi lõpust, kuigi efektiivsuse hindamise aeg sõltus ravitava nakkuse liigist.
English: International non-proprietary name (INN): garenoxacin mesylate
Estonian: Rahvusvaheline mittekaubanduslik nimetus (INN): garenoksatsiin
English: It was also unclear whether the medicine had an effect on the control of glucose (sugar) levels in the body.
Estonian: Ei olnud ka selge, kas ravim mõjutab vere glükoosisisalduse reguleerimist kehas.
English: Ref. EMEA/374268/2007
Estonian: London, 16. august 2007 Viitedokument EMEA/374268/2007